The therapeutic vaccines are a priority research line of the HIVACAT, the catalan programme for the development of therapeutic vaccines and prevent1
The Journal PLoS Medicine has published a monograph of 12 articles which outline the main conclusions of the Malaria Eradication Research Agenda (mal1
La revista Avances en Diabetología (AvD) és l'òrgan d'expressió de la Sociedad Española de Diabetes (SED). L'any 2011 comença una nova etapa amb el D1
L’empresa ImmunNovative Developments, sorgida del grup de recerca d’Immunologia de l’Hospital Clínic que lidera el Dr. Francisco Lozano, ha estat gua1
This morning, the meeting to constitute the new José Carreras Research Institute against Leukaemia took place. The main aims of the new Institute are1
HEPTROMIC is the first research network funded by the European Commission devoted to the study of Hepatocellular Carcinoma (HCC). It is a 3-year tr1
It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field1
The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine. Between Octob1
The President of the Catalan Government (Generalitat de Catalunya), José Montilla, accompanied by the Minister of Science and Innovation, Cristina Ga1
